← Back to Search

Exoskeleton

Honda Walking Assist Device for Stroke

N/A
Waitlist Available
Led By Arun Jayaraman, PhD
Research Sponsored by Shirley Ryan AbilityLab
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months of at-home training
Awards & highlights

Study Summary

This trial is testing whether a Honda exoskeleton device is safe and effective for people with stroke to use at home.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months of at-home training
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months of at-home training for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
10 Meter Walk Test (10MWT)
HWA Device Log
Honda Training Experience Survey
Secondary outcome measures
6 Minute Walk Test (6MWT)
Activites-Specific and Balance Confidence Scale (ABC)
Fugl-Meyer Assessment of Motor Recovery after Stroke (FMA)
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Honda Walk Assist (HWA) GroupExperimental Treatment1 Intervention
Participants utilize HWA device at home for 2 months according to prescribed settings.
Group II: Control GroupActive Control1 Intervention
Participants complete prescribed exercise program at the Shirley Ryan AbilityLab gym for 2 months.

Find a Location

Who is running the clinical trial?

Shirley Ryan AbilityLabLead Sponsor
192 Previous Clinical Trials
14,857 Total Patients Enrolled
69 Trials studying Stroke
6,317 Patients Enrolled for Stroke
Honda R&D Americas, IncUNKNOWN
Arun Jayaraman, PhDPrincipal InvestigatorShirley Ryan AbilityLab
5 Previous Clinical Trials
227 Total Patients Enrolled
2 Trials studying Stroke
67 Patients Enrolled for Stroke

Media Library

Honda Walking Assist Device (HWA) (Exoskeleton) Clinical Trial Eligibility Overview. Trial Name: NCT04380363 — N/A
Stroke Research Study Groups: Control Group, Honda Walk Assist (HWA) Group
Stroke Clinical Trial 2023: Honda Walking Assist Device (HWA) Highlights & Side Effects. Trial Name: NCT04380363 — N/A
Honda Walking Assist Device (HWA) (Exoskeleton) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04380363 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any restrictions to participating in this clinical experiment?

"For this medical trial, 28 individuals aged 18-80 who have experienced stroke within the last year are being recruited. Additionally, candidates must demonstrate adequate cognitive function (MMSE score >17), be able to walk 10m without assistance, consent to randomization into one of two groups, and follow a three step command while seated unaided for 30 seconds."

Answered by AI

Is this experiment currently recruiting participants?

"According to data hosted on clinicaltrials.gov, the trial posted on June 30th 2021 is not presently seeking patients. Nonetheless, there are more than 1000 other medical trials actively recruiting at this time."

Answered by AI

What goals is this trial attempting to achieve?

"This clinical trial, which entails two months of remotely-administered training, intends to measure the Honda Training Experience Survey. The secondary aims involve quantifying passive range of motion in joints such as hips and ankles with PROM testing, gait analysis that considers walking speed without and with an HWA device using GAITrite®, and FGA (Functional Gait Assessment) assessing balance while ambulating backwards or on a narrow base of support -- all scored up to 30 points for minimal detectable change among chronic stroke patients."

Answered by AI

Does this study include elderly patients among its participants?

"This clinical trial is exclusive to those within the age range of 18 and 80. Alternatively, there are 38 trials available for participants below legal adulthood, while 1006 cater towards individuals above retirement age."

Answered by AI
~7 spots leftby Apr 2025